SYRESpyre Therapeutics, Inc.
$90.35+306% 1Y
$90.35
$22.1852 weeks$108.94
Is the business good?
Mixed
1 neutral, 3 without dataMargins steady. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Margin direction, 3 yearsStablederived
Margins have held roughly steady, a stable cost structure.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
On our screens:Most shorted stocks